U.S., July 31 -- ClinicalTrials.gov registry received information related to the study (NCT07093580) titled 'Study of S-892216 Long-acting Injectable (LAI) in Healthy Adult Participants' on July 23.
Brief Summary: The purpose of this study is to investigate the safety, tolerability, and pharmacokinetics (PK) of single- and multiple-dose administration of S-892216-LAI in healthy adults.
Study Start Date: July 21
Study Type: INTERVENTIONAL
Condition:
Healthy Participants
Intervention:
DRUG: S-892216-LAI
S-892216-LAI injection will be administered per schedule specified in the arm description.
DRUG: Placebo
S-892216-LAI matching placebo injection will be administered per schedule specified in the arm description.
Recruitment Status:...